Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5352314 | 0.74 | USP10 (0.45) | CNR1CNR2LMNAALDH1A1CHRM1 | |
| SCHEMBL5461187 | 0.71 | DRD2 (0.45) | CNR1CNR2LMNAALDH1A1CHRM1 | |
| SCHEMBL7440853 | 0.70 | CNR1 (0.52) | CNR1CNR2LMNAALDH1A1CHRM1 | |
| SCHEMBL8635323 | 0.67 | CNR1 (0.49) | CNR1CNR2LMNAALDH1A1CHRM1 | |
| SCHEMBL9732645 | 0.65 | PLA2G2A (0.61) | LMNAALDH1A1HDAC1HDAC2HDAC6 | |
| SCHEMBL7396359 | 0.64 | CNR1 (0.52) | CNR1CNR2LMNAALDH1A1CHRM1 | |
| SCHEMBL5465948 | 0.63 | MAPT (0.61) | LMNAALDH1A1CHRM1TP53MAPT | |
| SCHEMBL9583982 | 0.62 | PLA2G2A (0.48) | CNR1CNR2LMNAALDH1A1HDAC1 | |
| SCHEMBL29073992 | 0.61 | HTR6 (0.48) | CNR1CNR2LMNAALDH1A1TP53 | |
| SCHEMBL3234261 | 0.61 | LMNA (0.54) | LMNACHRM1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070287699-A1 | ANTIVIRAL AGENTS | VIROBAY, INC. (US) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287699-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | CNR1 4234/4885CNR2 4636/4885LMNA 4460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.